GulfBase Live Support

Julphar plans to invest Dh300 million over next five years: CEO

20/05/2025 05:00 AST

Gulf Pharmaceutical Industries (Julphar) plans to invest Dh300 million over the next five years to expand its manufacturing base and localise advanced pharmaceutical technologies, CEO Basel Ziyadeh confirmed on Monday.

In statements made to the Emirates News Agency (WAM) on the sidelines of the first day of the "Make it in the Emirates 2025", Ziyadeh said the investment will be made in collaboration with global partners and aims to support the UAE's non-oil economy by increasing pharmaceutical exports.

He added that Julphar currently exports over 80% of its production to around 40 markets worldwide, underscoring the strength of its manufacturing infrastructure and local talent. Over the past three years, the company has already invested Dh100 million in upgrades and introduced more than 35 new products for both local and international markets.

Established over 45 years ago, Julphar is now one of the largest pharmaceutical manufacturers in the Arab region.

Gulfnews

News

Julphar H1 revenue grows 4.7% to $192.57m

15/08/2025

Gulf Pharmaceutical Industries (Julphar) has reported a steady revenue growth, an expansion in operating profits, and an improvement in its financial position during the second quarter and first half

Trade Arabia

Julphar named top pharma company in UAE

04/04/2018

Julphar, a leading pharmaceutical manufacturer in the region, has been ranked as the number one pharmaceutical company in the UAE by IMS Health February 2018 panel, reflecting a strong double digit s

Trade Arabia

Julphar records Dh1.3b in turnover for 2017

07/03/2018

Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales of Dh1.3 billion for the year ending December 31, 2017, despite a challenging and rapidly changi

Gulf News